NCT01545908View on ClinicalTrials.gov

Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Ulcerative Colitis
Interventions
OTHER

Fecal transplant

Participants in this arm undergo 6 retention enemas,using stool specimen prepared from a healthy, screened unrelated donor.

OTHER

Placebo enema

Patients will receive placebo enema, week 1, week 2, week 3, week 4, week 5, week 6

Trial Locations (2)

L8N 3Z5

Hamilton Health Sciences / McMaster University, Hamilton

L8N 4A6

St. Joseph's Hamilton Healthcare, Hamilton

All Listed Sponsors
lead

Hamilton Health Sciences Corporation

OTHER

NCT01545908 - Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis | Biotech Hunter | Biotech Hunter